Jane Street Group, LLC Agios Pharmaceuticals, Inc. Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

A detailed history of Jane Street Group, LLC transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 126,505 shares of AGIO stock, worth $4.35 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

126,505

Previous 176,815 28.45%

Holding current value

$4.35 Million

Previous $7.62 Million 26.29%

% of portfolio

0.0%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$41.19 - $49.72 $2.07 Million - $2.5 Million	-50,310 Reduced 28.45%	126,505 $5.62 Million
Q2 2024 Aug 14, 2024	BUY	$27.55 - $48.83 $1.44 Million - $2.55 Million	52,280 Added 41.98%	176,815 $7.62 Million
Q1 2024 May 15, 2024	BUY	$21.32 - $34.81 $565,278 - $922,952	26,514 Added 27.05%	124,535 $3.64 Million
Q4 2023 Feb 14, 2024	BUY	$19.97 - $24.53 $858,630 - $1.05 Million	42,996 Added 78.14%	98,021 $2.18 Million
Q3 2023 Nov 14, 2023	SELL	$24.36 - $28.18 $355,534 - $411,287	-14,595 Reduced 20.96%	55,025 $1.36 Million
Q2 2023 Aug 14, 2023	BUY	$21.38 - $29.19 $941,767 - $1.29 Million	44,049 Added 172.26%	69,620 $1.97 Million
Q1 2023 May 15, 2023	SELL	$21.74 - $30.93 $90,112 - $128,204	-4,145 Reduced 13.95%	25,571 $587,000
Q4 2022 Feb 14, 2023	BUY	$24.81 - $31.52 $737,253 - $936,648	29,716 New	29,716 $834,000
Q2 2022 Aug 16, 2022	BUY	$17.06 - $31.42 $730,867 - $1.35 Million	42,841 Added 560.89%	50,479 $1.12 Million
Q1 2022 May 17, 2022	SELL	$26.68 - $34.81 $1.61 Million - $2.1 Million	-60,461 Reduced 88.78%	7,638 $222,000
Q4 2021 Feb 15, 2022	BUY	$29.58 - $49.78 $28,219 - $47,490	954 Added 1.42%	68,099 $2.24 Million
Q3 2021 Nov 16, 2021	BUY	$41.92 - $58.18 $1.52 Million - $2.1 Million	36,170 Added 116.77%	67,145 $3.1 Million
Q2 2021 Aug 16, 2021	SELL	$52.06 - $61.27 $1.51 Million - $1.77 Million	-28,938 Reduced 48.3%	30,975 $1.71 Million
Q1 2021 May 18, 2021	BUY	$44.23 - $57.5 $607,985 - $790,395	13,746 Added 29.77%	59,913 $3.09 Million
Q4 2020 Feb 17, 2021	SELL	$33.21 - $46.54 $524,352 - $734,820	-15,789 Reduced 25.48%	46,167 $2 Million
Q3 2020 Nov 17, 2020	BUY	$33.87 - $55.93 $1.72 Million - $2.84 Million	50,739 Added 452.34%	61,956 $2.17 Million
Q2 2020 Aug 17, 2020	SELL	$34.45 - $53.48 $142,657 - $221,460	-4,141 Reduced 26.96%	11,217 $600,000
Q4 2019 Feb 14, 2020	BUY	$30.08 - $50.59 $68,792 - $115,699	2,287 Added 17.5%	15,358 $733,000
Q3 2019 Nov 14, 2019	BUY	$32.4 - $49.58 $423,500 - $648,060	13,071 New	13,071 $424,000
Q2 2019 Aug 15, 2019	SELL	$46.17 - $68.1 $257,536 - $379,861	-5,578 Closed	0 $0
Q1 2019 May 16, 2019	BUY	$45.92 - $67.67 $256,141 - $377,463	5,578 New	5,578 $376,000
Q4 2018 Feb 15, 2019	SELL	$42.73 - $76.53 $761,149 - $1.36 Million	-17,813 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$71.67 - $91.95 $986,250 - $1.27 Million	13,761 Added 339.61%	17,813 $1.37 Million
Q2 2018 Aug 15, 2018	BUY	$73.22 - $99.55 $296,687 - $403,376	4,052 New	4,052 $341,000

Others Institutions Holding AGIO

# of Institutions

232

Shares Held

58.1M

Call Options Held

403K

Put Options Held

469K

View Full List

About AGIOS PHARMACEUTICALS, INC.

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $1.89B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

More about AGIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Agios Pharmaceuticals, Inc. Transaction History